ANGO vs BIO · rev $292.5M vs rev $2.58B
AngioDynamics Inc (ANGO) versus BIO (BIO) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
BIO (BIO) common stock.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported BIO revenue for 2025-12-31 was $2.58B. Net income was $759.9M. Revenue was up 0.7% from 2024-12-31 to 2025-12-31. BIO currently screens at market cap $0.
ANGO currently screens at market cap $378.5M. BIO currently screens at market cap $0.
Not investment advice. Open the ANGO and BIO stock pages for the full models.
Not investment advice.